Skip to main content

Advertisement

Log in

Large Mass Affecting Retroperitoneal Great Vessels: A Rare Presentation of A Cancer of Unknown Primary with Diagnostic Dilemma and Challenged Surgical Intervention

  • BRIEF COMMUNICATION
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

Cancers of unknown primary site (CUPs) consist of a clinical entity which accounts for 3–5% of all solid tumor patients. They are metastatic solid tumors whose fundamental characteristic is the absence of identifiable site of the primary tumor.

Case Report

We report the case of a completely asymptomatic 34-year-old man with a palpated huge mass found incidentally in the left abdomen. All the investigations were normal. During the operation, a large mass was identified 2 cm below the left renal artery which was displacing and encompassing the great retroperitoneal vessels and the left ureter. A complete resection of the mass was performed while the histological examination revealed a solitary retroperitoneal lymph node categorized as metastatic adenocarcinoma of unknown primary site.

Conclusion

It is essential to assess the high incidence of patients with cancer who present with CUP. Early surgical excision of the metastatic lesion followed by adjuvant combination chemotherapy should be considered for patients with only a single site of malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Levi F, Te VC, Erler G, Randimbison L, La Vecchia C. Epidemiology of unknown primary tumors. Eur J Cancer. 2002;38:1810–1812.

    Article  PubMed  CAS  Google Scholar 

  2. van de Wouw AJ, Janssen-Heijnen MLG, Coebergh JWW, Hillen HF. Epidemiology of unknown primary tumors; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984–1992. Eur J Cancer. 2002;38:409–413.

    Article  PubMed  Google Scholar 

  3. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39:1990–2005.

    Article  PubMed  CAS  Google Scholar 

  4. Casciato DA. Metastases of unknown origin. In: Casciato DA, editor. Manual of clinical oncology. 5th ed. Philadelphia: Lippincott; 2004. p. 402–413.

    Google Scholar 

  5. Pentheroudakis G, Briasoulis E, Pavlidis N. Cancer of unknown primary site: missing primary or missing biology? Oncologist. 2007;12:418–425.

    Article  PubMed  CAS  Google Scholar 

  6. Briasoulis E, Pavlidis N. Cancer of unknown primary origin. Oncologist. 1997;2:142–152.

    PubMed  Google Scholar 

  7. Greco FA, Hainsworth JD. Cancer of unknown primary site. In: DeVita TV, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. Philadelphia: Lippincott; 1997. p. 2423–2443.

    Google Scholar 

  8. Bugat R, Bataillard A, Lesimple T, Voigt JJ, Culine S, Lortholary A, et al. Summary of the standards, options, and recommendations for the management of patients with carcinoma of unknown primary site (2002). Br J Cancer. 2003;89(Suppl 1):s59–s66.

    Article  PubMed  Google Scholar 

  9. Lembersky BC, Thomas LC. Metastases of unknown primary site. Med Clin North Am. 1996;80:153–171.

    Article  PubMed  CAS  Google Scholar 

  10. Briasoulis E, Kalofonos H, Bafaloukos D, Samantas E, Fountzilas G, Xiros N, et al. Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. J Clin Oncol. 2000;18:3101–3107.

    PubMed  CAS  Google Scholar 

  11. Culine S, Fabbro M, Ychou M, Romleu G, Cupissol D, Pujol H. Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary site. Cancer. 2002;94:840–846.

    Article  PubMed  CAS  Google Scholar 

  12. Greco FA, Gray J, Burris HA III, Erland JB, Morrissey LH, Hainsworth JD. Taxane-based chemotherapy for patients with carcinoma of unknown primary site. Cancer J. 2001;7:203–212.

    PubMed  CAS  Google Scholar 

  13. Saghatchian M, Fizazi K, Borel C, Ducreux M, Ruffie P, Le Chevalier T, et al. Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation—results of a prospective study. Ann Oncol. 2001;12:535–540.

    Article  PubMed  CAS  Google Scholar 

  14. Piga A, Nortilli R, Cetto GL, Cardarelli N, Fedeli SL, Fiorentini G, et al. Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site. Br J Cancer. 2004;90:1898–1904.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stavros Gourgiotis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stakia, P., Lagos, P., Gourgiotis, S. et al. Large Mass Affecting Retroperitoneal Great Vessels: A Rare Presentation of A Cancer of Unknown Primary with Diagnostic Dilemma and Challenged Surgical Intervention. J Gastrointest Canc 40, 55–58 (2009). https://doi.org/10.1007/s12029-009-9076-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-009-9076-9

Keywords

Navigation